This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Official event dates: January 11–15, 2021
Post-show access until March 31, 2021

Christopher Mortko
Associate VP at Merck & Co Inc.


Christopher Mortko Ph.D., MBA is an Associate Vice President and Head of Search and Evaluation in the Business Development and Licensing organization of Merck Research Laboratories.

 In this role, Chris leads a team responsible for the search, scientific evaluation, and due diligence for late stage research and development opportunities across all therapeutic areas. He is a key member of Merck’s Science, Strategy, and Business review governance committee that is responsible for decision making and deal structure/terms for business development opportunities. 

Prior to joining Merck business development, Christopher was a Senior Biotechnology Equity Analyst on Wall Street, focusing on oncology, immunology, and other therapeutic areas. Earlier in his career he was a research scientist at Merck and was involved in drug discovery and development across a number of therapeutic areas including oncology. 

Christopher received his undergraduate education at Fordham University in New York. He received a PhD in Organic Chemistry from the University of California, Los Angeles and completed an MBA at the NYU Stern School of Business.

Agenda Sessions

  • Oncology: The in-rush of funds for IO and non-IO

    On Demand

Speakers at this event